DGS Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $621K | Sell |
1,683
-633
| -27% | -$233K | 0.16% | 131 |
|
2024
Q3 | $1.2M | Buy |
2,316
+58
| +3% | +$30.2K | 0.33% | 59 |
|
2024
Q2 | $1.22M | Buy |
2,258
+84
| +4% | +$45.5K | 0.34% | 49 |
|
2024
Q1 | $1.13M | Buy |
2,174
+1,022
| +89% | +$530K | 0.32% | 53 |
|
2023
Q4 | $543K | Sell |
1,152
-119
| -9% | -$56.1K | 0.21% | 90 |
|
2023
Q3 | $553K | Sell |
1,271
-25
| -2% | -$10.9K | 0.27% | 85 |
|
2023
Q2 | $576K | Sell |
1,296
-279
| -18% | -$124K | 0.29% | 79 |
|
2023
Q1 | $724K | Sell |
1,575
-19
| -1% | -$8.74K | 0.4% | 48 |
|
2022
Q4 | $818K | Buy |
1,594
+123
| +8% | +$63.1K | 0.53% | 38 |
|
2022
Q3 | $668K | Buy |
1,471
+84
| +6% | +$38.2K | 0.45% | 36 |
|
2022
Q2 | $669K | Buy |
1,387
+119
| +9% | +$57.4K | 0.54% | 33 |
|
2022
Q1 | $623K | Buy |
1,268
+124
| +11% | +$60.9K | 0.38% | 42 |
|
2021
Q4 | $530K | Buy |
+1,144
| New | +$530K | 0.33% | 50 |
|